Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.64 USD | +9.82% | +3.98% | +0.84% |
05-10 | Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Cassava Sciences Raises More Than $125 Million From Warrant Distribution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.84% | 989M | |
+4.83% | 111B | |
+12.22% | 105B | |
-12.77% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.80% | 16.96B | |
+4.56% | 13.7B | |
+36.78% | 12.45B |
- Stock Market
- Equities
- SAVA Stock
- News Cassava Sciences, Inc.
- B. Riley Cuts Cassava Sciences' PT to $28 From $44 on 'Uninterpretable' Open-Label Results of Simuflam in Alzheimer's Disease Patients; Keeps Neutral Rating